KMDA · Kamada Ltd
United States · RS rating 49 · As of 2026-11-03
| Price | 7.25 USD |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 36 / 69 / 58 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 34 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -33.3% |
| Sales growth Q/Q | -5.0% |
| Distance from 52-week high | +22.1% |
| Market cap (USD) | $478.1M |